You searched for "Refractive"
Outcomes of adult new-onset strabismus presenting acutely
This study evaluated causes, neuroimaging rates and results, and clinical courses of adults presenting to an ophthalmology emergency department with diagnosis of new-onset strabismus. This was a retrospective study of 557 adults (54.8% male) with mean age of 57.3 ±16.7...
Management of strabismus due to orbital wall fractures
The authors present a retrospective single centre review of patients with strabismus due to orbital wall fractures with regard to their clinical presentation and outcomes. The study included 347 patients; 87% male and mean age of 32.42 ±12.9 years. Ten...RayOne EMV honoured with King’s Award for Enterprise
Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens. Launched in 2020 and...PACK-crosslinking for infectious keratitis
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...Preoperative povidone iodine: weighing the risks
Following on from our recent online survey, the authors examine the potential risks and benefits of diluting the concentration preoperative povidone iodine. Povidone iodine (PI) is an iodophore that has an established use as a broad-spectrum antiseptic, mainly for the...My Top Five: Emerging technologies revolutionising ophthalmology
Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...
Oxymetazoline hydrochloride for improved symmetry in Graves’ disease
Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial alpha 2 agonist that stimulates Muller’s muscle to lift the lid. The authors of this...ST3 Trainee experience of cataract surgery training in high flow settings in the independent sector
As an ST3 trainee, I was provided with the opportunity to complete a surgical training rotation at Newmedica Middlesborough, which involved cataract training on NHS patients undergoing surgery in the independent sector (IS). This reflective account highlights the experience from...
